Browse studies, page 1313
Page 1313 of 1,318, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial BMC infectious diseases, 2021
- Evaluation of empiric antibiotic de-escalation in febrile neutropenia Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016
- Helicobacter pylori antimicrobial resistance in a pediatric population Helicobacter, 2018
- In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates The Journal of antimicrobial chemotherapy, 2024
- Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia The Japanese journal of antibiotics, 2014
- Analysis of acenocoumarol and levofloxacin interaction in elderly institutionalized patients Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2019
- Safety of prolonged high-dose levofloxacin therapy for bone infections Journal of chemotherapy (Florence, Italy), 2007
- Brucellar reproductive system injury: A retrospective study of 22 cases and review of the literature The Journal of international medical research, 2020
- Appraisal of the cardiovascular risks of azithromycin: an observational analysis Journal of comparative effectiveness research, 2017
- Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections International journal of clinical pharmacy, 2018
- A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model The Journal of antimicrobial chemotherapy, 2025
- Levofloxacin susceptibility of Staphylococci from conjunctiva in patients with atopic dermatitis Japanese journal of ophthalmology, 2024
- Systematic Evaluation of Helicobacter pylori Susceptibility to Antibiotics Before First-Line Treatment: A Cohort Study United European gastroenterology journal, 2025
- Predictors of therapeutic exposure and pharmacokinetic variability of second-line anti-TB drugs in MDR-TB patients: a retrospective study Infection, 2025
- Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae Journal of medical microbiology, 2021
- Clinical Experience of Using a Combination of Dexamethasone and Levofloxacin After Cataract Surgery Medical archives (Sarajevo, Bosnia and Herzegovina), 2024
- Analysis of drug resistance and treatment efficacy of Helicobacter pylori infection in children Zhonghua er ke za zhi = Chinese journal of pediatrics, 2025
- Helicobacter pylori infection. Frequency of first-line treatment failure Medicina, 2020
- Best Treatment Options for Severe Helicobacter pylori Infections The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2025
- Perioperative Antibiotic Prophylaxis in Radical Prostatectomy: "Single-Shot" versus Multiday Regimen Urologia internationalis, 2023
- A treatment method for chronic suppurative lacrimal canaliculitis using chalazion forceps Indian journal of ophthalmology, 2016
- Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients Transplantation and cellular therapy, 2022
- Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024 World journal of gastroenterology, 2025
- Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study Journal of global antimicrobial resistance, 2024
- Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021
- Burn Wound Infections With Staphylococcus aureus: Clinical Characteristics and Risk Factors for Methicillin-Resistant Strains International wound journal, 2026
- Comparative Effectiveness of Single-Dose vs. Multi-Dose Prophylactic Antibiotics in Reducing Post-Surgical Infections: A Systematic Review and Meta-Analysis International journal of microbiology, 2026
- Diagnostic accuracy of the passive mast cell activation test in neuromuscular blocking agent-induced perioperative anaphylaxis in a tertiary hospital in China: a diagnostic accuracy study BMJ open, 2026
- Renal allograft malakoplakia mimicking malignancy: the value of combined morphological and functional imaging Clinical kidney journal, 2026
- Fluoroquinolone Use and Risk of Pneumothorax in Adults Hospitalized With Community Acquired Pneumonia: A Retrospective Cohort Study The clinical respiratory journal, 2026
- Enhanced Biofilm Disruption in Methicillin-Resistant Staphylococcus aureus Using Rifampin and Fluoroquinolone Combinations Pathogens (Basel, Switzerland), 2025
- Concomitant Versus Tailored Therapy Based on Antibiotic Resistance Profiles for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis JGH open : an open access journal of gastroenterology and hepatology, 2025
- Tildrakizumab in the Treatment of Complex and Severe Psoriasis: A Case Series Journal of clinical medicine, 2026
- Antimicrobial Susceptibility Determination of Less Frequently Isolated Legionella Species by Broth and Agar Dilution Antibiotics (Basel, Switzerland), 2025
- Radiologically Measured Renal Pelvis Urine Density Is Associated with Severe Infectious Complications After Ureteroscopy for Ureteral Stones: A Post Hoc Analysis of a Multicenter Prospective Study European urology open science, 2025
- QT Prolongation, Ventricular Arrhythmia, and Cardiac Arrest Signals During Ceftriaxone Co-therapy with Individual Proton Pump Inhibitors: A Multidatabase Study Cardiovascular toxicology, 2026
- The Resistance Landscape of Uropathogens in a Romanian Tertiary Center: A 13-Month Single-Center Study with Focus on Klebsiella and Urease-Positive Organisms Microorganisms, 2026
- An Injectable, Self-Healing Hydrogel Based on G-Quadruplexes/Phenylboronic Acid Composites with Antibacterial Activity Gels (Basel, Switzerland), 2026
- Indian Society of Critical Care Medicine Guidelines on Evidence-based Recommendations for the Treatment of Carbapenem-resistant Enterobacterales, Carbapenem-resistant Acinetobacter baumannii, and Carbapenem-resistant Pseudomonas aeruginosa in Critically Ill Patients: A GRADE-guided Approach Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2026
- Preheating colistimethate sodium enhances its efficacy against multi/extensively drug-resistant Gram-negative bacilli in preservation fluid Scientific reports, 2026
- Emergence of amoxicillin resistance in refractory Helicobacter pylori infection Therapeutic advances in gastroenterology, 2025
- Prevalence and Risk Factors of Fluoroquinolone Resistance in Major Bacterial Pathogens: A Systematic Review and Meta-Analysis International journal of microbiology, 2026
- Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and Guidance Infection and drug resistance, 2026
- Clinical impact of high-dose esomeprazole-amoxicillin dual therapy as rescue treatment for Helicobacter pylori infection: a meta-analysis of randomized controlled trials Gut pathogens, 2026
- Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia International journal of microbiology, 2026
- Wohlfahrtiimonas chitiniclastica: a potential disruptor of wound healing and glucose metabolism in diabetic foot ulcers Frontiers in microbiology, 2026
- QT prolongation in participants receiving bedaquiline-containing regimens: analysis of data from Phase 3 STREAM Stage 2 IJTLD open, 2026
- Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis The Journal of infectious diseases, 2025
- Clinical response to clozapine in Black people with psychosis: A secondary analysis of an open-label clinical trial Therapeutic advances in psychopharmacology, 2026
- Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant Tuberculosis Open forum infectious diseases, 2025
- Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs BMC health services research, 2026
- A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent Studies Cancers, 2026
- Limited Role of Mycoplasma genitalium, Chlamydia trachomatis, and Neisseria gonorrhoeae in Pelvic Inflammatory Disease and Tubo-Ovarian Abscess in the Netherlands: A Multicenter Prospective Cohort Study Obstetrics and gynecology international, 2026
- Case Report: Pulmonary nocardiosis: three case reports and literature review Frontiers in medicine, 2026
- Prophylactic azithromycin for chronic lung allograft dysfunction following lung transplantation: a systematic review and meta-analysis Journal of thoracic disease, 2025
- Benzoxaborole-Based Inhibitors Block LexA Autocleavage and Suppress SOS-Dependent Adaptive Phenotypes in Escherichia coli Antibiotics (Basel, Switzerland), 2026
- Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies Including Second-Line Therapy The Korean journal of helicobacter and upper gastrointestinal research, 2026
- Screening and tuberculosis preventive treatment among household contacts of drug-resistant tuberculosis patients: a scoping review BMC infectious diseases, 2026
- Epidemiological Characteristics and Antimicrobial Resistance of Prototheca Isolated in China During 2002-2024 Infection and drug resistance, 2026
- Levofloxacin-Induced Cutaneous Adverse Reactions: Characteristics and Rational Use Strategies Medical science monitor : international medical journal of experimental and clinical research, 2026
- Prevalence of primary Helicobacter pylori antibiotic resistance in Europe over the past four decades Gut microbes, 2026
- Antimicrobial resistance trends among dominant pathogens in six clinical departments of the Fourth Affiliated Hospital of Guangxi Medical University, 2020-2024 Frontiers in public health, 2026
- Bacteriological Spectrum and Antibiotic Utilization in Community-Acquired Pneumonia: An Observational Study at a Tertiary Care Center in Western Uttar Pradesh, India Cureus, 2026
- A Multifunctional Bioactive Nanoscale Coating Deposited by Atmospheric Pressure Plasma Polymerization of Peppermint Essential Oil Small (Weinheim an der Bergstrasse, Germany), 2026
- Dietary Intake Analyses for the Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis (PandrTB) Pharmacokinetic Sub-Study of the endTB and endTB-Q Clinical Trials 2026
- Ceftolozane/Tazobactam for Complex and Resistant Infections: Systematic Reviews of Comparative Efficacy Studies Antibiotics (Basel, Switzerland), 2026
- QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial 2025
- Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients Clinical therapeutics, 2006
- Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam BMC infectious diseases, 2017
- QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial PLOS global public health, 2026
- Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008
- Helicobacter pylori Antibiotic Resistance in Russia: A Systematic Review and Meta-Analysis Antibiotics (Basel, Switzerland), 2025
- Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort Infection, 2013
- Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019
- Global Population Structure, Virulence Factors and Antibiotic Resistance of Helicobacter pylori: A Pooled Analysis of 4067 Isolates From 76 Countries Helicobacter, 2025
- Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006 Clinical therapeutics, 2007
- Quality of Life and Patient Satisfaction at 7-Year Follow-up of Antibiotic Therapy vs Appendectomy for Uncomplicated Acute Appendicitis: A Secondary Analysis of a Randomized Clinical Trial JAMA surgery, 2020
- Regional difference of antibiotic resistance of helicobacter pylori strains in Korea The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011
- Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial BMC infectious diseases, 2019
- Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials The Journal of antimicrobial chemotherapy, 2017
- Levofloxacin for the treatment of pneumonia caused by Streptococcus pneumoniae including multidrug-resistant strains: pooled analysis Current medical research and opinion, 2009
- Effects of three fluoroquinolones on QT analysis after standard treatment courses Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2006
- Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial The Journal of antimicrobial chemotherapy, 2016
- Changes of resistance rates in Pseudomonas aeruginosa strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection Medicina intensiva, 2020
- Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study BMC oral health, 2022
- Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies Drug safety, 2004
- Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis Tropical medicine and infectious disease, 2024
- Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages British journal of clinical pharmacology, 2012
- High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam Tropical medicine and infectious disease, 2020
- Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005
- Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017-2018 International journal of environmental research and public health, 2021
- Levofloxacin treatment of active tuberculosis and the risk of adverse events Chest, 2005
- Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments The American journal of emergency medicine, 2022
- The Efficacy and Safety of Minocycline-Containing Quadruple Therapies Against Helicobacter pylori Infection: A Retrospective Cohort Study Infection and drug resistance, 2024
- A Randomized, Observer-Blinded, Active-Controlled, Phase IIIb Study to Compare IV/Oral Delafloxacin Fixed-Dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections: The DRESS Study Open forum infectious diseases, 2025
- Clinical utility of oral Nemonoxacin 500 mg once daily for the treatment of acute lower urinary tract infections: a prospective open-label, multicenter study BMC infectious diseases, 2025
- Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201) BMC cancer, 2024
- Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial The Lancet. Infectious diseases, 2026
- Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3) Antimicrobial agents and chemotherapy, 2025
- Base curves of bandage contact lenses and their effects on post Trans-PRK vision and pain: the study protocol for a randomized clinical trial Trials, 2025
